International Journal of Medical Anesthesiology
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal
P-ISSN: 2664-3766
E-ISSN: 2664-3774
Journal is inviting manuscripts for its coming issue. Contact us for more details.

2023, Vol. 6, Issue 1, Part A

Empirical aspect of usage of total intravenous anesthesia


Author(s): Dr. Sachin Narayan Rathore and Dr. Sony Baby

Abstract: Target-controlled infusion (TCI) of propofol and remifentanil is "ideal" total intravenous anaesthesia because it effectively blunts the body's reaction to pain (TIVA). Since all propofol TCI models have been shown to be reliable in clinical practise, there is currently no proof to recommend using one over the other. For both the induction and maintenance stages of TIVA, it is crucial to titrate the effect-site dosage to patient response. Since TIVA produces a profound level of anaesthesia, a treated EEG device is typically recommended to avoid overhypnosis. TIVA raises consciousness when a drug is not given due to a technological glitch, so being on the lookout for this kind of mistake is crucial.

DOI: 10.33545/26643766.2023.v6.i1a.374

Pages: 51-56 | Views: 509 | Downloads: 258

Download Full Article: Click Here

International Journal of Medical Anesthesiology
How to cite this article:
Dr. Sachin Narayan Rathore, Dr. Sony Baby. Empirical aspect of usage of total intravenous anesthesia. Int J Med Anesthesiology 2023;6(1):51-56. DOI: 10.33545/26643766.2023.v6.i1a.374
Call for book chapter
International Journal of Medical Anesthesiology